The effect of Astragalus polysaccharide on the Epstein-Barr virus lytic cycle
Option 3: Research peptides (gray area but low risk) Pathway: Find reputable research peptide supplier Order "for research purposes" Use at own risk Advantages: Much cheaper than prescription No doctor visit required Wide selection available Quick access Disadvantages: Gray legal area (not illegal but not approved) No medical oversight Quality varies by supplier No recourse if something goes wrong You assume all risk If going this route: Use reputable suppliers only (third-party testing) Start with conservative doses Understand you're in gray area legally (though low practical risk) See our best peptide vendors guide for quality sourcing
Generally, individual injection doses are smaller than a full IV dose, because very high amounts of NAD under the skin can be uncomfortable
Further randomized trials with larger sample sizes, including NAFLD patients with and without diabetes and incorporating active control groups, are needed to confirm these findings [45]
[3] Regular follow-up every 3-6 months enables ongoing cardiovascular risk assessment, medication optimization, and prompt evaluation of any new symptoms
This adjustment period is when fatigue is often at its peak
